Ema Partners India Ltd vs Sheel Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 22, 2026

Key Highlights

The Latest Trading Price of EMA Partners India Ltd is ₹ 72.8 as of 20 Mar 15:30 . The P/E Ratio of EMA Partners India Ltd changed from 20.3 on March 2025 to 20.3 on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Sheel Biotech Ltd changed from 0 on March 2022 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 years The Market Cap of EMA Partners India Ltd changed from ₹ 256.64 crore on March 2025 to ₹ 256.64 crore on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Sheel Biotech Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 years The Dividend Payout of EMA Partners India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sheel Biotech Ltd changed from 28.46 % on March 2022 to 14.05 % on March 2025 . This represents a CAGR of -16.18% over 4 years .

About EMA Partners India Ltd

EMA Partners India Limited was originally incorporated as a Private Limited Company in the name and style of 'Executive Management Associates India Private Limited' dated September 9, 2003.
The Company name was changed from 'Executive Management Associates India Private Limited' to 'EMA Partners India Private Limited' pursuant to fresh Certificate of Incorporation dated February 4, 2004 issued by the RoC, Mumbai, Maharashtra.
Subsequently, the status was converted into Public Limited Company and the name of the Company was changed to 'EMA Partners India Limited' and a fresh Certificate of Incorporation was issued by RoC, Central Processing Centre on August 05, 2024. The Company is a leading executive search firm delivering bespoke leadership hiring solutions to clients across diverse sectors.

About Sheel Biotech Ltd

Sheel Biotech Limited was incorporated as a Private Company as 'Sheel Biotech Private Limited' dated November 26, 1991, with the Registrar of Companies, Delhi & Haryana.
Further, Company was converted into a Public Limited Company w.e.f.
April 02, 1992. The Company was founded by Dr. Satya Narayan Chandak in 1991.
Thereafter, through his vision he led the stone of Tissue Culture lab wherein for advancement of lab he deputed two of his scientists to Netherlands for training to expand the business ventured in domestic market too and then added greenhouse division to promote protected cultivation.
The Company started the Import division in 2019 and importing tulip, glad, lilium, orchids and alstromeria.

FAQs for the comparison of EMA Partners India Ltd and Sheel Biotech Ltd

Which company has a larger market capitalization, EMA Partners India Ltd or Sheel Biotech Ltd?

Market cap of EMA Partners India Ltd is 169 Cr while Market cap of Sheel Biotech Ltd is 99 Cr

What are the key factors driving the stock performance of EMA Partners India Ltd and Sheel Biotech Ltd?

The stock performance of EMA Partners India Ltd and Sheel Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for EMA Partners India Ltd and Sheel Biotech Ltd?

As of March 22, 2026, the EMA Partners India Ltd stock price is INR ₹72.8. On the other hand, Sheel Biotech Ltd stock price is INR ₹49.05.

How do dividend payouts of EMA Partners India Ltd and Sheel Biotech Ltd compare?

To compare the dividend payouts of EMA Partners India Ltd and Sheel Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.